Ashish Mandelia, VP, Controller: Mersana Therapeutics MRSN Sell · Filed 23/01/18

Trade details

Type: Insider sale
Amount: $20,520.5
Shares · price: 3,575 sh · $5.74 a share
Held after: 13,619 sh
Stock: Mersana Therapeutics MRSN
Person: Ashish MandeliaVP, Controller
Trade date: 23/01/17
Filed: 23/01/18
Days to filing: 1 days

Sold 20.8% of holdings

Share of holding sold: 20.8%

Mersana Therapeutics trades, last 26 weeks

What else happened in Mersana Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/18~23/02/16

Ashish Mandelia's recent trades

Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$2,061
3,554 sh
$2,061
Filed 25/01/17
Traded 25/01/16
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$1,128
1,791 sh
$1,128
Filed 25/01/16
Traded 25/01/15
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$665
1,007 sh
$665
Filed 25/01/15
Traded 25/01/14
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$9,710
4,855 sh
$9,710
Filed 24/10/07
Traded 24/10/02
Ashish MandeliaVP, Chief Accounting Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$6,588
3,361 sh
$6,588
Filed 24/10/07
Traded 24/10/03